Boxer Capital, LLC
- SEC CIK
- 0001465837
- Latest filing
- Feb 14, 2025
Holdings in Q4 2021
Holdings as of Dec 31, 2021, filed Feb 14, 2022. Long positions only; changes compare share counts with Q3 2021.
- Positions
- 70
- −17 vs. Q3 2021
- Portfolio value
- $2.51B
- −$350.1M (−12.2%) vs. Q3 2021
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| MRTXMirati Therapeutics, Inc. | COM | 2,000,000 | $293.4M | 11.7% | 00.0% | Unchanged | History |
| State Street SPDR S&P Biotech ETF78464A870 | ETF | 2,200,000 | $246.3M | 9.8% | +2,200,000 | New | – |
| ITOSiTeos Therapeutics, Inc. | COM | 4,345,016 | $202.3M | 8.0% | 00.0% | Unchanged | History |
| ONCBeOne Medicines Ltd. | ADR | 500,000 | $135.5M | 5.4% | −264,188−34.6% | Reduced | History |
| SWTXSpringWorks Therapeutics, Inc. | COM | 2,075,905 | $128.7M | 5.1% | 00.0% | Unchanged | History |
| CYTKCytokinetics Inc | COM NEW | 2,100,000 | $95.7M | 3.8% | 00.0% | Unchanged | History |
| TYRATyra Biosciences, Inc. | COM | 6,448,359 | $90.7M | 3.6% | +125,000+2.0% | Added | History |
| RVMDRevolution Medicines, Inc. | COM | 3,484,264 | $87.7M | 3.5% | 00.0% | Unchanged | History |
| RLAYRelay Therapeutics, Inc. | COM | 2,669,132 | $82.0M | 3.3% | +1,375,000+106.2% | Added | History |
| TNGXTango Therapeutics, Inc. | COM | 6,871,642 | $75.2M | 3.0% | 00.0% | Unchanged | History |
| PMVPPMV Pharmaceuticals, Inc. | COM | 2,838,236 | $65.6M | 2.6% | +570,000+25.1% | Added | History |
| MRUSMerus N.V. | COM | 1,900,000 | $60.4M | 2.4% | 00.0% | Unchanged | History |
| RCUSArcus Biosciences, Inc. | COM | 1,432,200 | $58.0M | 2.3% | −652,683−31.3% | Reduced | History |
| BPMCBlueprint Medicines Corp | COM | 507,374 | $54.3M | 2.2% | +82,374+19.4% | Added | History |
| IDYAIDEAYA Biosciences, Inc. | COM | 2,202,812 | $52.1M | 2.1% | 00.0% | Unchanged | History |
| SAGESage Therapeutics, Inc. | COM | 1,094,000 | $46.5M | 1.9% | 00.0% | Unchanged | History |
| ANABAnaptysbio, Inc | COM | 1,300,000 | $45.2M | 1.8% | 00.0% | Unchanged | History |
| NUVBNuvation Bio Inc. | COM CL A | 4,341,009 | $36.9M | 1.5% | 00.0% | Unchanged | History |
| NRIXNurix Therapeutics, Inc. | COM | 1,224,892 | $35.5M | 1.4% | 00.0% | Unchanged | History |
| KNTEKinnate Biopharma Inc. | COM | 1,847,559 | $32.7M | 1.3% | 00.0% | Unchanged | History |
| RCKTRocket Pharmaceuticals, Inc. | COM | 1,466,051 | $32.0M | 1.3% | 00.0% | Unchanged | History |
| FATEFate Therapeutics Inc | COM | 500,000 | $29.3M | 1.2% | +500,000 | New | History |
| GOSSGossamer Bio, Inc. | COM | 2,462,358 | $27.8M | 1.1% | 00.0% | Unchanged | History |
| FOLDAmicus Therapeutics, Inc. | COM | 2,325,000 | $26.9M | 1.1% | 00.0% | Unchanged | History |
| Avidity Biosciences, Inc.05370A108 | COM | 1,121,327 | $26.7M | 1.1% | 00.0% | Unchanged | – |
| Bellus Health Inc New07987C204 | COM NEW | 3,200,000 | $25.8M | 1.0% | +225,000+7.6% | Added | – |
| GHRSGH Research PLC | ORDINARY SHARES | 1,013,399 | $23.6M | 0.9% | 00.0% | Unchanged | History |
| NUVLNuvalent, Inc. | COM | 1,210,192 | $23.0M | 0.9% | 00.0% | Unchanged | History |
| IOVAIovance Biotherapeutics, Inc. | COM | 1,100,000 | $21.0M | 0.8% | 00.0% | Unchanged | History |
| DAWNDay One Biopharmaceuticals, Inc. | Stock | 1,189,943 | $20.1M | 0.8% | 00.0% | Unchanged | History |
| XENEXenon Pharmaceuticals Inc. | COM | 600,000 | $18.7M | 0.7% | −257,000−30.0% | Reduced | History |
| ALGSAligos Therapeutics, Inc. | COM | 1,526,048 | $18.1M | 0.7% | 00.0% | Unchanged | History |
| AKROAkero Therapeutics, Inc. | COM | 831,495 | $17.6M | 0.7% | 00.0% | Unchanged | History |
| RAREUltragenyx Pharmaceutical Inc. | COM | 200,000 | $16.8M | 0.7% | +200,000 | New | History |
| CGEMCullinan Therapeutics, Inc. | COM | 1,074,082 | $16.6M | 0.7% | 00.0% | Unchanged | History |
| Rain Oncology Inc.75082Q105 | COM | 1,175,000 | $15.1M | 0.6% | 00.0% | Unchanged | – |
| PRTAProthena Corp Public Ltd Co | SHS | 300,000 | $14.8M | 0.6% | 00.0% | Unchanged | History |
| MISTMilestone Pharmaceuticals Inc. | COM | 2,238,861 | $14.7M | 0.6% | −333,333−13.0% | Reduced | History |
| CNTACentessa Pharmaceuticals plc | SPONSORED ADS | 1,251,137 | $14.1M | 0.6% | −83,090−6.2% | Reduced | History |
| PNTPOINT Biopharma Global Inc. | COM | 2,500,000 | $14.0M | 0.6% | 00.0% | Unchanged | History |
| BCABBioAtla, Inc. | COM | 686,347 | $13.5M | 0.5% | 00.0% | Unchanged | History |
| THRXTheseus Pharmaceuticals, Inc. | COM | 892,057 | $11.3M | 0.5% | +892,057 | New | History |
| BDTXBlack Diamond Therapeutics, Inc. | COM | 2,014,858 | $10.7M | 0.4% | 00.0% | Unchanged | History |
| RNACCartesian Therapeutics, Inc. | COM | 3,284,072 | $10.7M | 0.4% | 00.0% | Unchanged | History |
| EPIXESSA Pharma Inc. | COM NEW | 724,500 | $10.3M | 0.4% | +37,500+5.5% | Added | History |
| CDAKCodiak BioSciences, Inc. | COM | 850,065 | $9.47M | 0.4% | −180,000−17.5% | Reduced | History |
| NGMNGM Biopharmaceuticals Inc | COM | 500,000 | $8.86M | 0.4% | 00.0% | Unchanged | History |
| BMEABiomea Fusion, Inc. | COM | 1,188,405 | $8.85M | 0.4% | −900,000−43.1% | Reduced | History |
| LITSLite Strategy, Inc. | COM NEW | 2,913,091 | $7.78M | 0.3% | 00.0% | Unchanged | History |
| EQRXEQRx, Inc. | COM | 1,000,000 | $6.82M | 0.3% | +1,000,000 | New | History |
| BCELAtreca, Inc. | CL A COM | 2,202,333 | $6.67M | 0.3% | 00.0% | Unchanged | History |
| ODTOdonate Therapeutics, Inc. | COM | 4,207,086 | $5.68M | 0.2% | −1,400,000−25.0% | Reduced | History |
| SLDBSolid Biosciences Inc. | COM | 3,177,702 | $5.56M | 0.2% | −556,872−14.9% | Reduced | History |
| ELEVElevation Acquisition Group Inc. | COM | 872,780 | $5.25M | 0.2% | −468,750−34.9% | Reduced | History |
| BCLS Acquisition CorpG0904B105 | COM CL A | 500,000 | $4.90M | 0.2% | 00.0% | Unchanged | – |
| JYACJiya Acquisition Corp. | COM CL A | 500,000 | $4.88M | 0.2% | 00.0% | Unchanged | History |
| RACBResearch Alliance Corp. II | COM CL A | 500,000 | $4.88M | 0.2% | 00.0% | Unchanged | History |
| Panacea Acquisition Corp. IIG6882C106 | CL A SHS | 500,000 | $4.85M | 0.2% | 00.0% | Unchanged | – |
| ACADAcadia Pharmaceuticals Inc | COM | 185,000 | $4.32M | 0.2% | +185,000 | New | History |
| OBIOOrchestra BioMed Holdings, Inc. | ORD SHS | 400,000 | $4.03M | 0.2% | 00.0% | Unchanged | History |
| MLTXMoonLake Immunotherapeutics | COM CL A | 400,000 | $3.96M | 0.2% | 00.0% | Unchanged | History |
| IRONDisc Medicine, Inc. | COM | 1,300,000 | $3.78M | 0.2% | 00.0% | Unchanged | History |
| DBVTDBV Technologies S.A. | SPONSORED ADR | 2,134,598 | $3.42M | 0.1% | −5,400,000−71.7% | Reduced | History |
| ORICOric Pharmaceuticals, Inc. | COM | 200,000 | $2.94M | 0.1% | 00.0% | Unchanged | History |
| CABACabaletta Bio, Inc. | COM | 540,000 | $2.05M | 0.1% | −1,063,361−66.3% | Reduced | History |
| Omega Alpha SpacG6749V107 | CL A | 200,000 | $1.95M | 0.1% | 00.0% | Unchanged | – |
| TARAProtara Therapeutics, Inc. | COM STK | 209,227 | $1.41M | 0.1% | 00.0% | Unchanged | History |
| GNCAGenocea Biosciences, Inc. | COM NEW | 1,134,453 | $1.32M | 0.1% | 00.0% | Unchanged | History |
| SRZNSurrozen, Inc. | COM | 200,000 | $1.29M | 0.1% | 00.0% | Unchanged | History |
| Nuvation Bio Inc.67080N119 | *W EXP 07/07/202 | 266,666 | $504.0K | <0.1% | 00.0% | Unchanged | – |
Options (1)
Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.
| Security | Class | Puts | Calls |
|---|---|---|---|
| SPDR Ser Tr78464A900 | CALL | – | $61.6M |
Sold out since Q3 2021 (23)
Positions held at the end of Q3 2021 that are gone from this filing.
| Security | Class | Shares in Q3 2021 | Value in Q3 2021 | % of portfolio in Q3 2021 | History |
|---|---|---|---|---|---|
| ARGXArgenx SE | SPONSORED ADR | 170,926 | $51.6M | 1.8% | History |
| CNTBConnect Biopharma Holdings Ltd | ADS | 2,081,323 | $50.4M | 1.8% | History |
| SNDXSyndax Pharmaceuticals Inc | COM | 2,287,782 | $43.7M | 1.5% | History |
| FULCFulcrum Therapeutics, Inc. | COM | 1,250,000 | $35.3M | 1.2% | History |
| TPTXTurning Point Therapeutics, Inc. | COM | 525,000 | $34.9M | 1.2% | History |
| MRNSMarinus Pharmaceuticals, Inc. | COM NEW | 2,400,000 | $27.3M | 1.0% | History |
| KURAKura Oncology, Inc. | COM | 1,050,289 | $19.7M | 0.7% | History |
| PASGPassage BIO, Inc. | COM | 1,928,315 | $19.2M | 0.7% | History |
| SPRYARS Pharmaceuticals, Inc. | COM | 1,675,377 | $16.7M | 0.6% | History |
| FSTXF-star Therapeutics, Inc. | COM | 1,751,428 | $12.8M | 0.4% | History |
| Achilles Therapeutics PLC00449L102 | SPONSORED ADS | 1,536,016 | $12.0M | 0.4% | – |
| NGNENeurogene Inc. | COM | 1,501,058 | $10.9M | 0.4% | History |
| TLISTalis Biomedical Corp | COM | 1,550,998 | $9.69M | 0.3% | History |
| IMMPIMMUTEP Ltd | SPONSORED ADS | 2,500,000 | $9.68M | 0.3% | History |
| ERASErasca, Inc. | COM | 450,000 | $9.55M | 0.3% | History |
| VINCVincerx Pharma, Inc. | COM NEW | 450,000 | $7.28M | 0.3% | History |
| ASMBAssembly Biosciences, Inc. | COM | 1,500,000 | $5.22M | 0.2% | History |
| NAUTNautilus Biotechnology, Inc. | COM | 750,000 | $4.61M | 0.2% | History |
| LJPCLa Jolla Pharmaceutical Co | COM PAR $.0001 2 | 890,700 | $3.55M | 0.1% | History |
| KNSAKiniksa Pharmaceuticals International, plc | COM CL A | 290,577 | $3.31M | 0.1% | History |
| Direxion Shs ETF Tr25460G716 | DAILY S&P BIOTEC | 150,000 | $3.19M | 0.1% | – |
| SNCEScience 37 Holdings, Inc. | COM | 200,000 | $1.96M | 0.1% | History |
| CLRBCellectar Biosciences, Inc. | COM PAR | 920,000 | $851.0K | <0.1% | History |